Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Government Policies to Back Brazilian Healthcare Sector

May 27, 2011
Share |
 
According to our latest report entitled Brazil Healthcare Market Analysis, healthcare market in Brazil has been growing at a fast pace for the past few years, thus making it one of the attractive industries in Latin America. The total expenditure on healthcare was valued at around US$ 168 Billion in 2010 that showcased the country’s ability and desire to provide effective medical services to the society. Factors, such as disease prevalence, strong investments, and the government initiatives are supporting the market dynamics. Thus, the healthcare spending is likely to grow at a CAGR of around 6% during 2010-2013 to reach US$ 201.6 Billion by 2013 end.
 
We have found that, several government programs and policies are being implemented to address key health related issues, which are critical in nature. Smiling Brazil, for example, is the national policy for oral health created by the government to expand the access of dental care to the population. The program has improved the condition of primary health in the country through investment and is further likely to strengthen healthcare market potential. Our report has covered these programs and other government initiatives in a prudent manner to show the efficacy of public sector in the Brazilian healthcare market.
 
The report Brazil Healthcare Market Analysis provides a description of healthcare market and major drivers that are boosting the revenue patterns. In the industry performance section, the report covers all the key aspects of the industry including pharmaceutical market, medical device sector, hospital services, and primary health. The report also investigates current trends prevailing in the market and analyzes their impact on the overall sector performance.
 
The report is an outcome of an extensive research and in depth analysis of the Brazilian healthcare industry, thus providing reliable statistics and effective presentation of the content. The report makes use of proper methods and techniques for the future outlook and forecast. Last though not the least, coverage of active market players completes the overall picture.

For more information visit: http://www.rncos.com/Report/IM261.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports